You are here

Study Evaluating The Safety, Tolerability, And Efficacy Of Switching From Quetiapine To Ziprasidone

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Phoenix, Arizona, 85028 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Schizophrenia, Schizoaffective Disorder
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-55 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Males or females, between 18 and 55 years of age, at the time of consent.

- Subjects must have a primary diagnosis of schizophrenia, any subtype (code 295.xx), or
schizoaffective disorder as defined in DSM-IV-TR (Diagnostic and Statistical Manual of
Mental Disorders - Fourth Edition)

- Subjects must have normal vital signs, physical examination, ECG, and laboratory
findings except for minor deviations determined and documented to be clinically
insignificant by the investigator or a sub-investigator who is a medical doctor.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Subjects who are unable to provide informed consent

- Subjects who meet criteria for a DSM-IV-TR Axis I (Diagnostic and Statistical Manual
of Mental Disorders - Fourth Edition) diagnosis other than schizophrenia or
schizoaffective disorder, including psychoactive substance abuse or dependence within
one year of study entry

- Females who are pregnant, breast feeding, or lactating at screening.

NCT00406315
Pfizer
Completed
Study Evaluating The Safety, Tolerability, And Efficacy Of Switching From Quetiapine To Ziprasidone

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now